Homo sapiens
Ontology highlight
ABSTRACT:
OTHER RELATED OMICS DATASETS IN: E-GEOD-26834
PROVIDER: PRJNA136041 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Expression data from MCF-7 cells stimulated by Estrogen or IGF-I
2025-01-24 | E-GEOD-26834 | ExpressionAtlas
Project description:Expression data from IGF-I-stimulated MCF-7 cells
| PRJNA100357 | ENA
Project description:Expression data for Control and SMRT-Depleted MCF-7 Cells
2025-01-24 | E-GEOD-57935 | ExpressionAtlas
Project description:Expression data of MCF-7 cells treated with gamma tocotrienol (g-T3)
2025-01-24 | E-GEOD-21946 | ExpressionAtlas
Project description:Gene expression data from MCF-7 cells treated with Lacciac Acid A
2025-01-24 | E-GEOD-45804 | ExpressionAtlas
Project description:MCF-7:PF is a a new in vitro model of antihormone resistant breast cancer that exhibits the characteristics of acquired tamoxifen resistance in vivo. It is well known that estrogen (E2) induces apoptosis in long-term estrogen-deprived breast cancer cells, MCF-7:5C (PubMed References PMID:15862958, PMID:16333030). MCF-7:PF was derived from MCF-7:5C through inhibition of c-Src, which blocks E2-induced apoptosis, coverts E2 responses from apoptosis to proliferation. MCF-7:PF cell growth is stimulated by E2 and SERMS in an ERα-dependent manner. Abstract: A c-Src inhibitor blocks estrogen (E2)-induced stress and converts E2 responses from inducing apoptosis to stimulating growth in E2-deprived breast cancer cells. A resulting cell line, MCF-7:PF, is reprogrammed with features of functional estrogen receptor (ER) and over-expression of insulin-like growth factor-1 receptor beta (IGF-1Rβ). We addressed the question of whether the antiestrogenic selective ER modulator 4-hydroxytamoxifen (4-OHT) could target ER to prevent E2-stimulated growth in MCF-7:PF cells. Unexpectedly, 4-OHT stimulated cell growth in an ER-dependent manner. However, unlike E2, 4-OHT suppressed classic ER-target genes as does the pure antiestrogen ICI 182,780, even during growth stimulation. Chromatin-immunoprecipitation (ChIP) assay indicated that 4-OHT did not recruit ER or nuclear receptor coactivator 3 (SRC3) to the promoter of ER-target gene, pS2. Paradoxically, 4-OHT reduced total IGF-1Rβ but increased phosphorylation of IGF-1Rβ, which was responsible for the activation of the phosphatidylinositol-3 kinases (PI3K)/Akt signaling pathway. Mechanistic studies revealed that 4-OHT rapidly activated the non-genomic pathway through ER, but other membrane-associated proteins such as IGF-1Rβ and c-Src participated. Furthermore, 4-OHT was more potent than E2 to up-regulate membrane remodeling molecules and activated focal adhesion molecules to promote cell growth. Therefore, disruption of membrane-associated signaling completely abolished 4-OHT-stimulated cell growth, but not E2-stimulated cell growth. Despite continued suppression of classic ER-target genes, 4-OHT activated the complex network of cytoskeleton remodeling and extracellular matrix-related signaling which facilitated 4-OHT-stimulated cell growth. This study is the first to recapitulate a cellular model in vitro of acquired tamoxifen (TAM) resistance developed in athymic mice in vivo.
2014-07-14 | GSE54171 | GEO
Project description:Transcription profiling by array of human MCF cells treated with estrogen
2025-01-16 | E-GEOD-11324 | ExpressionAtlas
Project description:Expression data of hormone-responsive MCF-7 cells versus estrogen-deprived MCF-7:5C and MCF-7:2A breast cancer cells
| PRJNA107269 | ENA
Project description:Gene expression profile of myeloma cells treated with IGF-1
2014-07-03 | E-GEOD-17140 | ExpressionAtlas
Project description:Transcription profiling by array of human hormone-responsive MCF-7 cells versus estrogen-deprived breast cancer cells
2025-01-16 | E-GEOD-10879 | ExpressionAtlas